Cargando…
A robust genomic signature for the detection of colorectal cancer patients with microsatellite instability phenotype and high mutation frequency#
Microsatellite instability (MSI) occurs in 10–20% of colorectal tumours and is associated with good prognosis. Here we describe the development and validation of a genomic signature that identifies colorectal cancer patients with MSI caused by DNA mismatch repair deficiency with high accuracy. Micro...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3532622/ https://www.ncbi.nlm.nih.gov/pubmed/22926706 http://dx.doi.org/10.1002/path.4092 |
_version_ | 1782254328884494336 |
---|---|
author | Tian, Sun Roepman, Paul Popovici, Vlad Michaut, Magali Majewski, Ian Salazar, Ramon Santos, Cristina Rosenberg, Robert Nitsche, Ulrich Mesker, Wilma E Bruin, Sjoerd Tejpar, Sabine Delorenzi, Mauro Bernards, Rene Simon, Iris |
author_facet | Tian, Sun Roepman, Paul Popovici, Vlad Michaut, Magali Majewski, Ian Salazar, Ramon Santos, Cristina Rosenberg, Robert Nitsche, Ulrich Mesker, Wilma E Bruin, Sjoerd Tejpar, Sabine Delorenzi, Mauro Bernards, Rene Simon, Iris |
author_sort | Tian, Sun |
collection | PubMed |
description | Microsatellite instability (MSI) occurs in 10–20% of colorectal tumours and is associated with good prognosis. Here we describe the development and validation of a genomic signature that identifies colorectal cancer patients with MSI caused by DNA mismatch repair deficiency with high accuracy. Microsatellite status for 276 stage II and III colorectal tumours has been determined. Full-genome expression data was used to identify genes that correlate with MSI status. A subset of these samples (n = 73) had sequencing data for 615 genes available. An MSI gene signature of 64 genes was developed and validated in two independent validation sets: the first consisting of frozen samples from 132 stage II patients; and the second consisting of FFPE samples from the PETACC-3 trial (n = 625). The 64-gene MSI signature identified MSI patients in the first validation set with a sensitivity of 90.3% and an overall accuracy of 84.8%, with an AUC of 0.942 (95% CI, 0.888–0.975). In the second validation, the signature also showed excellent performance, with a sensitivity 94.3% and an overall accuracy of 90.6%, with an AUC of 0.965 (95% CI, 0.943–0.988). Besides correct identification of MSI patients, the gene signature identified a group of MSI-like patients that were MSS by standard assessment but MSI by signature assessment. The MSI-signature could be linked to a deficient MMR phenotype, as both MSI and MSI-like patients showed a high mutation frequency (8.2% and 6.4% of 615 genes assayed, respectively) as compared to patients classified as MSS (1.6% mutation frequency). The MSI signature showed prognostic power in stage II patients (n = 215) with a hazard ratio of 0.252 (p = 0.0145). Patients with an MSI-like phenotype had also an improved survival when compared to MSS patients. The MSI signature was translated to a diagnostic microarray and technically and clinically validated in FFPE and frozen samples. Copyright © 2012 Pathological Society of Great Britain and Ireland. |
format | Online Article Text |
id | pubmed-3532622 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | John Wiley & Sons, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-35326222013-01-09 A robust genomic signature for the detection of colorectal cancer patients with microsatellite instability phenotype and high mutation frequency# Tian, Sun Roepman, Paul Popovici, Vlad Michaut, Magali Majewski, Ian Salazar, Ramon Santos, Cristina Rosenberg, Robert Nitsche, Ulrich Mesker, Wilma E Bruin, Sjoerd Tejpar, Sabine Delorenzi, Mauro Bernards, Rene Simon, Iris J Pathol Original Papers Microsatellite instability (MSI) occurs in 10–20% of colorectal tumours and is associated with good prognosis. Here we describe the development and validation of a genomic signature that identifies colorectal cancer patients with MSI caused by DNA mismatch repair deficiency with high accuracy. Microsatellite status for 276 stage II and III colorectal tumours has been determined. Full-genome expression data was used to identify genes that correlate with MSI status. A subset of these samples (n = 73) had sequencing data for 615 genes available. An MSI gene signature of 64 genes was developed and validated in two independent validation sets: the first consisting of frozen samples from 132 stage II patients; and the second consisting of FFPE samples from the PETACC-3 trial (n = 625). The 64-gene MSI signature identified MSI patients in the first validation set with a sensitivity of 90.3% and an overall accuracy of 84.8%, with an AUC of 0.942 (95% CI, 0.888–0.975). In the second validation, the signature also showed excellent performance, with a sensitivity 94.3% and an overall accuracy of 90.6%, with an AUC of 0.965 (95% CI, 0.943–0.988). Besides correct identification of MSI patients, the gene signature identified a group of MSI-like patients that were MSS by standard assessment but MSI by signature assessment. The MSI-signature could be linked to a deficient MMR phenotype, as both MSI and MSI-like patients showed a high mutation frequency (8.2% and 6.4% of 615 genes assayed, respectively) as compared to patients classified as MSS (1.6% mutation frequency). The MSI signature showed prognostic power in stage II patients (n = 215) with a hazard ratio of 0.252 (p = 0.0145). Patients with an MSI-like phenotype had also an improved survival when compared to MSS patients. The MSI signature was translated to a diagnostic microarray and technically and clinically validated in FFPE and frozen samples. Copyright © 2012 Pathological Society of Great Britain and Ireland. John Wiley & Sons, Ltd 2012-12 2012-10-12 /pmc/articles/PMC3532622/ /pubmed/22926706 http://dx.doi.org/10.1002/path.4092 Text en Copyright © 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. http://creativecommons.org/licenses/by/2.5/ Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation. |
spellingShingle | Original Papers Tian, Sun Roepman, Paul Popovici, Vlad Michaut, Magali Majewski, Ian Salazar, Ramon Santos, Cristina Rosenberg, Robert Nitsche, Ulrich Mesker, Wilma E Bruin, Sjoerd Tejpar, Sabine Delorenzi, Mauro Bernards, Rene Simon, Iris A robust genomic signature for the detection of colorectal cancer patients with microsatellite instability phenotype and high mutation frequency# |
title | A robust genomic signature for the detection of colorectal cancer patients with microsatellite instability phenotype and high mutation frequency# |
title_full | A robust genomic signature for the detection of colorectal cancer patients with microsatellite instability phenotype and high mutation frequency# |
title_fullStr | A robust genomic signature for the detection of colorectal cancer patients with microsatellite instability phenotype and high mutation frequency# |
title_full_unstemmed | A robust genomic signature for the detection of colorectal cancer patients with microsatellite instability phenotype and high mutation frequency# |
title_short | A robust genomic signature for the detection of colorectal cancer patients with microsatellite instability phenotype and high mutation frequency# |
title_sort | robust genomic signature for the detection of colorectal cancer patients with microsatellite instability phenotype and high mutation frequency# |
topic | Original Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3532622/ https://www.ncbi.nlm.nih.gov/pubmed/22926706 http://dx.doi.org/10.1002/path.4092 |
work_keys_str_mv | AT tiansun arobustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency AT roepmanpaul arobustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency AT popovicivlad arobustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency AT michautmagali arobustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency AT majewskiian arobustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency AT salazarramon arobustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency AT santoscristina arobustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency AT rosenbergrobert arobustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency AT nitscheulrich arobustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency AT meskerwilmae arobustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency AT bruinsjoerd arobustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency AT tejparsabine arobustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency AT delorenzimauro arobustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency AT bernardsrene arobustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency AT simoniris arobustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency AT tiansun robustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency AT roepmanpaul robustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency AT popovicivlad robustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency AT michautmagali robustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency AT majewskiian robustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency AT salazarramon robustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency AT santoscristina robustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency AT rosenbergrobert robustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency AT nitscheulrich robustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency AT meskerwilmae robustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency AT bruinsjoerd robustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency AT tejparsabine robustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency AT delorenzimauro robustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency AT bernardsrene robustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency AT simoniris robustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency |